Cartesian Therapeutics, Inc. (RNAC)
7.38
-0.89
(-10.76%)
USD |
NASDAQ |
May 15, 16:00
7.375
0.00 (0.00%)
After-Hours: 20:00
Cartesian Therapeutics Total Liabilities (Quarterly) : 436.51M for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Insmed, Inc. | 1.371B |
| Regeneron Pharmaceuticals, Inc. | 9.445B |
| Precision BioSciences, Inc. | 67.79M |
| ACADIA Pharmaceuticals, Inc. | 357.16M |
| Alnylam Pharmaceuticals, Inc. | 4.054B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 288.39M |
| Shareholders Equity (Quarterly) | -148.12M |
| Debt to Equity Ratio | -0.08 |
| Current Ratio | 7.654 |
| Net Debt Paydown Yield | 0.32% |